Infection & Immunity
The Burnet Institute is a major centre for research in infection and immunity.
An important focus is human immunodeficiency virus (HIV), in particular, understanding how HIV causes disease, treatment, eradication, identification of new drug targets and development of point-of-care testing.
Other research is directed towards understanding how the immune system functions in health as well as in disease, and on developing novel treatments for incurable and chronic diseases.
Read more on Burnet Institute infection and immunity research programs
The Monash Department of Immunology
The Monash Department of Immunology’s research programs are in basic and translational immunology, and target diseases including allergy, asthma, autoimmunity, inflammation, diabetes, organ fibrosis, cancer and malaria. The department also focuses on engineering novel treatments such as nanoparticle-based vaccines in cancer and infection, as well as therapeutic proteins and monoclonal antibodies.
Professor David Tarlinton, Head of Monash AMREP Department of Immunology and Pathology
Other Alliance research in infection and immunity
Spotlight on infection and immunity research
Burnet teams up with Monash and BioCurate to develop novel HIV antivirals
Burnet Institute, in collaboration with Monash Institute of Pharmaceutical Sciences (MIPS), received Proof of Concept funding from BioCurate to develop next-generation human immunodefi ciency virus (HIV) antivirals.